Oncology Infographic: Real-time Patient Insights from Medisafe

Infographics
Oncology Infographic: Real-time Patient Insights from Medisafe

Highlights from the Oncology Infographic

  • The U.S. ranks amongst the lowest in reported oncology aherence as compared to other developed nations
  • Unlike other therapeutic classes, patients on oncology meds are adherent every day of the week
  • The highest reported oncology adherence rates on Medisafe are prior to breakfast and dinner hours
  • Patients taking more oncology meds are more adherent
  • Of the top 10 most adherent cancer drugs on Medisafe, Amgen and Novartis hold two spots each


What insights can we discover about your brand? Contact us to find out!


Full Oncology Adherence Insights

Top 15 Most Adherent Countries For Cancer Meds

  • Italy: 84%
  • Switzerland: 84%
  • Brazil: 83%
  • Spain: 83%
  • Mexico: 82%
  • Canada: 81%
  • France: 81%
  • New Zealand: 81%
  • Germany: 80%
  • UK: 80%
  • Australia: 80%
  • USA: 79%
  • Chile: 74%
  • Israel: 74%
  • Netherlands: 72%

How Day Of Week Affects Cancer Med Adherence

  • Sunday: 82%
  • Monday: 84%
  • Tuesday: 83%
  • Wednesday: 84%
  • Thursday: 83%
  • Friday: 83%
  • Saturday: 82%

Adherence Rates By Type Of Cancer

  • Thyroid: 96%
  • Bone: 84%
  • Leukemia: 84%
  • Non-Hodgkin’s Lymphoma: 84%
  • Recovery/ Blood Cells: 84%
  • Colorectal: 78%
  • Gastric: 77%
  • Prostate: 77%
  • Renal: 77%
  • Breast: 76%
  • Melanoma: 76%
  • Lymphoma: 75%
  • Myeloma: 72%
  • Brain: 68%
  • Lung: 67%
  • Pancreatic: 60%

How Number Of Cancer Meds Influences Adherence

  • 1 Med: 85%
  • 2 Meds: 85%
  • 3 Meds: 86%
  • 4 Meds: 87%
  • 5 Meds: 88%
  • 6+ Meds: 90%

Top 10 Cancer Drugs With Highest Adherence

Brand Company Adherence
Xgeva Amgen 91%
Sprycel BMS 90%
Zometa Novartis 88%
Imbruvica Pharmacyclics 88%
Neupogen Amgen 84%
Palbociclib Pfizer 84%
Rituxan Biogen, Genetech 84%
Femara Novartis 84%
Zytiga Janssen Biotech 83%
Lenalidomide Celgene 81%

What insights can we discover about your brand? Contact us to find out!